<DOC>
	<DOCNO>NCT01005030</DOCNO>
	<brief_summary>The primary objective study determine utility blood plasma infrared spectroscopy ( biospectroscopy ) distinguish subject idiopathic Parkinson 's disease healthy control .</brief_summary>
	<brief_title>Spectroscopy Parkinson Disease</brief_title>
	<detailed_description>Oxidative stress implicate factor pathogenesis Parkinson 's disease ( PD ) . The overall goal proposal use novel metabolomics platform , base near infrared biospectroscopy , detect oxidatively modify blood plasma constituent . These spectral finding use model degree oxidative stress model `` stress index '' may distinguish PD case healthy elderly control .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>PD Subjects : 1 . PostCEPT subject diagnosis PD base UK Brain Bank criterion . 2 . Willing able provide inform consent . Healthy Controls : 1 . No current diagnosis know history neurological disease/disorder . 2 . Nonblood relative patient subject site diagnosis PD ( may include healthy control PROBE study ) . 3 . No first degree relative diagnosis PD 4 . MoCA score &gt; 26 . 5 . Age &gt; 45 . 6 . Willing able provide inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>46 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Parkinson Disease</keyword>
	<keyword>blood</keyword>
	<keyword>plasma</keyword>
	<keyword>metabolomics</keyword>
	<keyword>spectroscopy</keyword>
	<keyword>oxidative stress .</keyword>
</DOC>